Amphastar Pharmaceuticals, Inc. AMPH
Regular-session close
After hours · Nov 13, 4:00 PM ET
- YTD
- +9.67%
- 1 year
- +11.38%
AMPH free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
121,233,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 121,233,000 | -51,112,000 | -29.66% |
| FY 2024 | 2024-12-31 | 172,345,000 | 27,008,000 | 18.58% |
| FY 2023 | 2023-12-31 | 145,337,000 | 79,769,000 | 121.66% |
| FY 2022 | 2022-12-31 | 65,568,000 | -4,970,000 | -7.05% |
| FY 2021 | 2021-12-31 | 70,538,000 | 47,127,000 | 201.30% |
| FY 2020 | 2020-12-31 | 23,411,000 | 23,204,000 | 11209.66% |
| FY 2019 | 2019-12-31 | 207,000 | 8,579,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -8,372,000 | -12,482,000 | -303.70% |
| FY 2017 | 2017-12-31 | 4,110,000 | -13,068,000 | -76.07% |
| FY 2016 | 2016-12-31 | 17,178,000 | 22,493,000 | Not meaningful |
| FY 2015 | 2015-12-31 | -5,315,000 | -5,868,000 | -1061.12% |
| FY 2014 | 2014-12-31 | 553,000 | -12,187,000 | -95.66% |
| FY 2013 | 2013-12-31 | 12,740,000 | 38,052,000 | Not meaningful |
| FY 2012 | 2012-12-31 | -25,312,000 | -33,732,000 | -400.62% |
| FY 2011 | 2011-12-31 | 8,420,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-09T06:01:59.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.